Gastric Cancer Clinical Trials
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
I
Not yet recruiting
- Gastric Cancer
- +2 more
- Doxorubicin and Cisplatin
- London, United KingdomImperial College London, Hammersmith Hospital Campus
2022-04-01
Apr 1, 2022N
Recruiting
- Gastric Cancer
- +4 more
- Bethesda, MarylandNational Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022N
Not yet recruiting
- Gastric Cancer
- +2 more
- Cellvizio (Registered trademark) 100 microscope
- Olympus GIF 180 endoscope
- Bethesda, MarylandNational Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022N
Recruiting
- Gastric Adenocarcinoma
- +3 more
- Paclitaxel
- +2 more
- Bethesda, MarylandNational Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022S
Active, not recruiting
- Gastrointestinal Cancer
- +8 more
- Serious Illness Conversation Guide (SICG)
- Quality of Life (QOL) survey
- Stanford, CaliforniaStanford Cancer Center
2022-04-05
Apr 5, 2022N
Recruiting
- Gastrointestinal Cancer
- +4 more
- Cyclophosphamide
- +3 more
- Bethesda, MarylandNational Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022N
Recruiting
- Gastric Adenocarcinoma
- +2 more
- Surgery
- +3 more
- Bethesda, MarylandNational Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022N
Recruiting
- Pancreatic Cancer
- +4 more
- Cyclophosphamide
- +3 more
- Bethesda, MarylandNational Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022E
No longer available
- Gastric Cancer
- Gastroesophageal Junction Adenocarcinoma
- (no location specified)
2022-04-06
Apr 6, 2022N
Enrolling by invitation
- Esophageal Cancer
- Gastric Cancer
- Beijing, ChinaCancer Institute and hospital, Chinese Academy of Medical Scienc
2022-04-07
Apr 7, 2022M
Active, not recruiting
- Breast Cancer
- Gastric Cancer
- margetuximab
- Bethesda, Maryland
- +2 more
2022-04-05
Apr 5, 2022M
Recruiting
- Gastric Cancer
- Gastroesophageal Junction Cancer
- Pembrolizumab
- +7 more
- Beijing, Beijing, China
- +7 more
2022-04-06
Apr 6, 2022H
Recruiting
- Gastric Cancer
- +8 more
- Los Angeles, California
- +2 more
2022-04-05
Apr 5, 2022Q
Recruiting
- Gastric Cancer
- SHR1210
- +3 more
- Jinan, Shandong, ChinaQilu hospital of Shandong univertisy
2022-03-30
Mar 30, 2022N
Recruiting
- Pancreatic Cancer
- +15 more
- NGM831
- NGM831 plus pembrolizumab
- Grand Rapids, Michigan
- +2 more
2022-04-05
Apr 5, 2022A
Active, not recruiting
- Gastric Cancer
- olaparib
- +2 more
- Anyang, Korea, Republic of
- +13 more
2022-04-05
Apr 5, 2022S
Completed
- Gastric Cancer
- Gastroesophageal Junction Cancer
- BBI608
- +2 more
- Scottsdale, Arizona
- +262 more
2022-04-04
Apr 4, 2022L
Available
- Esophageal Neoplasm
- +9 more
- Birmingham, Alabama
- +3 more
2022-04-05
Apr 5, 2022D
Recruiting
- Liver Metastases
- +10 more
- DNX-2440
- Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute, Inc.
2022-03-28
Mar 28, 2022N
Recruiting
- Gastric Cancer
- Prehabilitation
- Vilnius, Lithuania
- +1 more
2022-04-05
Apr 5, 2022S
Withdrawn
- Peritoneal Carcinomatosis
- +6 more
- anti-CEA CAR-T cells
- New Brunswick, New Jersey
- +1 more
2022-03-25
Mar 25, 2022K
Completed
- Gastric Cancer
- Complication of Surgical Procedure
- No use of antimicrobial prophylaxis
- Use of antimicrobial prophylaxis
- Hwasun, Jellanamdo, Korea, Republic ofChonnam National University Hwasun Hospital
2022-03-28
Mar 28, 2022D
Active, not recruiting
- Gastric Cancer
- Esophagus Cancer
- Clayton, North Carolina
- +6 more
2022-03-28
Mar 28, 2022M
Recruiting
- Advanced Cancer
- +9 more
- Birmingham, Alabama
- +6 more
2022-04-04
Apr 4, 2022N
Not yet recruiting
- Pancreatic Cancer
- +15 more
- NGM438
- NGM438 plus pembrolizumab
- (no location specified)
2022-03-27
Mar 27, 2022